Relates to reporting on funds received pursuant to a New York opioid settlement sharing agreement.
Summary
Bill A06554 aims to amend the mental hygiene law concerning the management and reporting of funds received from opioid settlement agreements in New York. It requires relevant commissioners to provide an annual report detailing the utilization of these funds, including baseline funding for recipients, disbursement amounts, and the effectiveness of programs aimed at addressing substance use disorders. The report is to be made publicly available and should include evidence-based metrics to assess the impact of funded services on prevention, harm reduction, treatment, and recovery advancements.
Additionally, the bill restricts government entities from bringing lawsuits against parties released from claims in statewide opioid settlement agreements executed after June 1, 2021. This provision aims to clarify the legal landscape surrounding opioid settlements and prevent redundant legal actions that could undermine the agreements reached with opioid manufacturers and distributors.
Impact
If enacted, this bill will enhance transparency and accountability regarding the allocation and effectiveness of funds from opioid settlements in New York. It will establish a systematic approach for reporting on how these funds are utilized, which could influence future appropriations and funding decisions. The limitation on lawsuits will protect the integrity of the settlements and ensure that resources are focused on recovery and prevention efforts rather than legal disputes.
Sentiment
The sentiment around Bill A06554 appears to be generally supportive, as it addresses critical issues related to the opioid crisis and aims to ensure that settlement funds are used effectively. However, there may be concerns from some stakeholders regarding the limitations on legal actions, as this could affect the ability of local governments to seek justice against opioid manufacturers and distributors.
Contention
Notable points of contention may arise from the provision that limits the authority of government entities to file lawsuits against parties involved in opioid settlements. Some lawmakers and advocacy groups may argue that this restriction could hinder accountability and the pursuit of justice for communities affected by the opioid epidemic. Conversely, supporters may contend that it is necessary to protect the settlement agreements and focus on recovery efforts.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.
Requires the report on statewide opioid settlements include the amount of funds that have been spent and requires the public be provided information on how much funds have been spent.
Reforms the opioid settlement board to provide services and supports to grieving families and include board members who lost a child, sibling, parent or close family member to substance use disorder.